AI Institute for Molecular Discovery, Synthetic Strategy, and Manufacturing: Molecule Maker Lab Institute (MMLI)

NSF Award Search · 01002930DB NSF RESEARCH & RELATED ACTIVIT · $15,000,000 · view on nsf.gov ↗

Abstract

Over nearly two centuries, molecular synthesis has transformed the world by creating new molecular entities that have improved quality of life around the globe. This enterprise currently requires access to highly sophisticated equipment and extensive training. Established in 2020, the NSF Molecule Maker Lab Institute (MMLI) is dedicated to developing AI tools, automated workflows, and educational resources for the next generation of molecular innovators that will accelerate molecular discovery and broaden access to the expertise and sophisticated mechanics of molecular synthesis. The second phase of the institute (MMLI 2.0) focuses on the development and application of new foundational AI methods and generative AI models for molecule discovery and synthesis, as well as the dissemination of these tools to a broad research community. Synergistically, these activities are advancing the frontiers of AI with data requirements unique to molecular synthesis. MMLI2.0 further seeks to train a next-generation workforce with a unique set of skills in AI, chemistry, and robotics. This new generation of molecule makers represents the vanguard of innovators who will enable more efficient manufacturing and discovery of molecules with important functions and broaden access to the small molecule making process, achieving a powerful impact on the U.S. research community. Functional molecules play a critical role in addressing many grand challenges facing society today. However, the process

Key facts

NSF award ID
2505932
Awardee
University of Illinois at Urbana-Champaign (IL)
SAM.gov UEI
Y8CWNJRCNN91
PI
Huimin Zhao
Primary program
01002930DB NSF RESEARCH & RELATED ACTIVIT
All programs
Artificial Intelligence (AI), Biotechnology, COMPUTATIONAL SCIENCE & ENGING
Estimated total
$15,000,000
Funds obligated
$4,000,000
Transaction type
Cooperative Agreement
Period
09/01/2025 → 08/31/2030